BHARAT IMMUNOLOGICALS cash-and-equivalents fundamental analysis lookup allows you to check this and other indicators for BHARAT IMMUNOLOGICALS BIOLOG or any other equity instrument. You can also select from a set of available indicators by clicking on the link to the right. Please note, not all equities are covered by this module due to inconsistencies in global equity categorizations. Please check also Equity Screeners to view more equity screening tools

BHARAT IMMUNOLOGICALS Cash and Equivalents Analysis

Cash or Cash Equivalents are the most liquid of all assets found on company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.
Bank Deposits 
More About Cash and Equivalents | All Equity Analysis
BHARAT IMMUNOLOGICALS Cash and Equivalents  =
182.85 M
BHARAT IMMUNOLOGICALS ValuationFundamentalsBuy or Sell

About Cash and Equivalents

Cash equivalents represent current assets that are easily convertible to cash such as short term bonds, savings account, money market funds, or certificate of deposits (CDs). One of the important consideration companies make when classifying assets as cash equivalent is that investments they report on their balance sheets under current assets should have almost no risk of change in value over the next few months (usually 3 months).Compare to competition
In accordance with recently published financial statements BHARAT IMMUNOLOGICALS BIOLOG has 182.85 M in Cash and Equivalents. This is 77.72% lower than that of the Healthcare sector, and 59.1% lower than that of Biotechnology industry, The Cash and Equivalents for all stocks is 93.23% higher than the company.

BHARAT IMMUNOLOGICALS Cash and Equivalents Peer Comparison

BHARAT IMMUNOLOGICALS is currently under evaluation in cash and equivalents category among related companies.

BHARAT IMMUNOLOGICALS current financial ratios